Opioid therapy for chronic pain: Difference between revisions
Jump to navigation
Jump to search
(/* Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT){{cite web |u...) |
|||
Line 4: | Line 4: | ||
===Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT)<ref name="urlNational Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain.">{{cite web |url=http://www.guideline.gov/content.aspx?id=16313&search=opioid+therapy+guidelines |title=National Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. |format= |work= |accessdate=2012-11-28}}</ref>=== | ===Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT)<ref name="urlNational Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain.">{{cite web |url=http://www.guideline.gov/content.aspx?id=16313&search=opioid+therapy+guidelines |title=National Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. |format= |work= |accessdate=2012-11-28}}</ref>=== | ||
{| | {|Assessment | ||
Patient with Chronic Pain | |||
Recommendations | |||
A trial of opioid therapy (OT) is indicated for a patient with chronic pain who meets all of the following criteria: | |||
Moderate to severe pain that has failed to adequately respond to indicated non-opioid and non-drug therapeutic interventions | |||
The potential benefits of OT are likely to outweigh the risks (i.e., no absolute contraindications) | |||
The patient is fully informed and consents to the therapy | |||
Clear and measurable treatment goals are established | |||
The ethical imperative is to provide the pain treatment with the best benefit-to-harm profile for the individual patient. | |||
|} | |} | ||
Revision as of 11:19, 28 November 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]